1. Home
  2. TBLA vs AORT Comparison

TBLA vs AORT Comparison

Compare TBLA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.37

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$44.62

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
AORT
Founded
2007
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
2.1B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
TBLA
AORT
Price
$4.37
$44.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$4.80
$49.36
AVG Volume (30 Days)
1.7M
333.4K
Earning Date
11-05-2025
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,880,771,000.00
$422,646,000.00
Revenue This Year
$11.25
$15.97
Revenue Next Year
$5.55
$10.96
P/E Ratio
$56.86
N/A
Revenue Growth
10.96
9.81
52 Week Low
$2.50
$21.97
52 Week High
$4.65
$48.25

Technical Indicators

Market Signals
Indicator
TBLA
AORT
Relative Strength Index (RSI) 60.58 40.08
Support Level $3.93 $45.75
Resistance Level $4.65 $48.00
Average True Range (ATR) 0.14 1.36
MACD 0.04 -0.20
Stochastic Oscillator 66.68 9.43

Price Performance

Historical Comparison
TBLA
AORT

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: